NIH-U01: Quantitative Imaging for Evaluation of Response to Cancer Therapies

Objecte

This Funding Opportunity Announcement (FOA) invites research project – cooperative agreement (U01) applications which are expected to enhance the value of quantitative imaging (QI) in clinical trials for prediction and/or measurement of response to cancer therapies. One avenue for this enhancement is to emphasize the development, optimization and validation of state-of-the-art QI methods and software tools for potential implementation in single site phase 1 or 2 clinical trials. The second avenue to enhance QI methods is to address the challenges of integrating existing and or new QI methods as required for multicenter phase 3 clinical trials. This may involve evaluation of a range of multimodal imaging approaches, harmonization of image data collection, analysis, display and clinical workflow methods across imaging platforms, or testing their performance across different cancer sites.

Because this validation process is complex, a single research program cannot be expected to complete every detail from initial tool development to final integration into clinical trials. Therefore, it is anticipated that these research goals will require multidisciplinary efforts. Although the involvement of industrial partners in the development of the QI methods is not required, it is strongly encouraged. Awardees will also join the Quantitative Imaging Network (QIN) to share ideas and approaches in order to validate and standardize imaging data and related imaging metadata for quantitative measurements of prediction and/or response to cancer therapies.
 

Termini IISPV

1- Declaration of interest: IISPV’s deadline: August 31, 2014(europa@iispv.cat)

2- NIH Register; create PI account(s); affiliate PI account to IISPV, etc.

3. Full proposal: IISPV’s deadline: September 22, 2014, 2014

Termini Oficial

Official deadline: October 05, 2014

Estàs interessat?

Omple el següent formulari per rebre més informació: